Abstract
859-P: ALN-KHK, an Investigational RNA Interference Therapeutic, Successfully Targets Hepatic Ketohexokinase in a Single Ascending Dose Study of Overweight to Obese Adults
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have